Analyst Ranking
Top 34%
#1656 out of 4937 analysts
Average Return
+0.2%
Win Rate
48%166 out of 344
Risk vs Reward
Poor
Good

Matthew Harrison's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Moderna IncMRNA
+267.87%$37.25$137.03
2020-04-14 -
2020-12-16
Strong Buy
Fusion Pharmaceuticals IncFUSN
+235.08%$3.25$10.89
2023-01-26 -
2024-01-26
Strong Buy
Insmed IncINSM
+226.56%$21.99$71.81
2023-08-03 -
2024-08-02
Strong Buy
Loxo Oncology IncLOXO
+185.28%$43.47$124.01
2017-04-02 -
2018-03-21
Strong Buy
Denali Therapeutics IncDNLI
+180.06%$20.01$56.04
2020-04-14 -
2021-04-15
Strong Buy

Matthew Harrison Analyst Color

Get additional color on Matthew Harrison's coverage of popular stocks

Matthew Harrison's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Regeneron Pharmaceuticals IncREGN
32Strong Buy$754.00+32.81%Maintains
2 days ago
Legend Biotech CorpLEGN
9Strong Buy$81.00+107.91%Maintains
2 days ago
Vertex Pharmaceuticals IncVRTX
21Hold$460.00-1.89%Maintains
22 days ago
Sarepta Therapeutics IncSRPT
26Hold$40.00+120.14%Downgrades
25 days ago
Insmed IncINSM
12Strong Buy$102.00+3.89%Maintains
a month ago
Gilead Sciences IncGILD
30Strong Buy$135.00+23.13%Maintains
3 months ago
Atea Pharmaceuticals IncAVIR
9Hold$6.00+63.49%Maintains
3 months ago
Biogen IncBIIB
32Hold$152.00+13.26%Maintains
3 months ago
Moderna IncMRNA
18Hold$32.00-4.88%Maintains
3 months ago
2seventy Bio IncTSVT
9Hold$5.000.00%Maintains
4 months ago
Tenaya Therapeutics IncTNYA
4Strong Buy$5.00+632.06%Maintains
4 months ago
Denali Therapeutics IncDNLI
8Strong Buy$33.00+127.27%Assumes
4 months ago
Live Nation Entertainment IncLYV
1Strong Buy$178.00+23.66%Maintains
5 months ago
Avient CorpAVNT
1Buy$56.00+63.69%Upgrades
5 months ago
Comcast CorpCMCSA
2Strong Buy$55.00+57.19%Maintains
5 months ago
Alector IncALEC
7Strong Sell$3.00+86.34%Downgrades
8 months ago
Io Biotech IncIOBT
5Strong Buy$6.00+308.16%Maintains
10 months ago
Centessa Pharmaceuticals PLCCNTA
9Hold$11.00N/AMaintains
a year ago
Zentalis Pharmaceuticals IncZNTL
4Hold$8.00N/ADowngrades
a year ago
Argenx SeARGX
10Strong Buy$510.00N/AMaintains
a year ago
Editas Medicine IncEDIT
9Hold$7.00N/AUpgrades
a year ago
Biomarin Pharmaceutical IncBMRN
17Strong Buy$112.00N/AMaintains
a year ago
Pharvaris NvPHVS
14Strong Buy$34.00N/AMaintains
a year ago
Genmab AGMAB
18Strong Sell$32.00N/AMaintains
a year ago
Cerevel Therapeutics Holdings IncCERE
6Strong Buy$38.00N/AMaintains
2 years ago
Barinthus Biotherapeutics PLCBRNS
5Hold$3.25N/ADowngrades
2 years ago
Beone Medicines LtdONC
11Strong Buy$319.00N/AMaintains
2 years ago
Prime Medicine IncPRME
3Hold$19.00N/AMaintains
2 years ago
Seagen IncSGEN
15Hold$229.00N/AReiterates
2 years ago
Bluebird Bio IncBLUE
28Strong Sell$60.00N/AReiterates
2 years ago
Sigilon Therapeutics IncSGTX
7Hold$21.00N/AMaintains
2 years ago
Vigil Neuroscience IncVIGL
3Hold$13.00N/AMaintains
2 years ago
Invivyd IncIVVD
7Strong Sell$1.00N/AMaintains
2 years ago
Innoviva IncINVA
7Strong Sell$10.00N/AMaintains
2 years ago
Fulcrum Therapeutics IncFULC
7Hold$8.00N/ADowngrades
2 years ago
Galapagos NvGLPG
14Hold$44.00N/AMaintains
2 years ago
Fusion Pharmaceuticals IncFUSN
3Strong Buy$10.00N/AMaintains
2 years ago
Sana Biotechnology IncSANA
2Strong Buy$13.00N/AMaintains
2 years ago
Lyell Immunopharma IncLYEL
4Hold$80.00N/AMaintains
2 years ago
Bolt Biotherapeutics IncBOLT
4Hold$60.00N/AMaintains
2 years ago
Biontech SeBNTX
6Hold$216.00N/AMaintains
2 years ago
Adc Therapeutics SaADCT
8Hold$5.00N/AMaintains
2 years ago
Adagene IncADAG
5Strong Buy$5.00N/AMaintains
2 years ago
Abbvie IncABBV
7Strong Buy$182.00N/AMaintains
3 years ago
Kodiak Sciences IncKOD
5Hold$9.00N/AMaintains
3 years ago
Akero Therapeutics IncAKRO
5Hold$40.00N/AMaintains
3 years ago
Amgen IncAMGN
20Strong Buy$282.00N/AMaintains
3 years ago
Alnylam Pharmaceuticals IncALNY
6Hold$210.00N/AMaintains
3 years ago
Kalaris Therapeutics IncKLRS
7Strong Buy$621.00N/AMaintains
3 years ago
Johnson & JohnsonJNJ
3Hold$173.00N/AMaintains
3 years ago
Pfizer IncPFE
4Hold$55.00N/AMaintains
3 years ago
Merck & Co IncMRK
4Hold$82.00N/AMaintains
4 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
8Hold$145.00N/AMaintains
4 years ago
Kaleido Biosciences IncKLDO
3Strong Sell$3.00N/ADowngrades
4 years ago
Sage Therapeutics IncSAGE
3Hold$78.00N/AMaintains
4 years ago
Bristol Myers Squibb CoBMY
2Hold$66.00N/AMaintains
4 years ago
Taysha Gene Therapies IncTSHA
2Strong Buy$39.00N/AMaintains
4 years ago
Royalty Pharma PLCRPRX
1Hold$46.00N/AMaintains
4 years ago
Organon & CoOGN
1Hold$35.00N/AMaintains
4 years ago
Enliven Therapeutics IncELVN
3Hold$12.00N/ADowngrades
4 years ago
Eli Lilly & CoLLY
1Strong Buy$275.00N/AMaintains
4 years ago
Grupo Televisa SabTV
1Strong Buy$19.00N/AInitiates Coverage On
4 years ago
Evelo Biosciences IncEVLO
7Hold$260.00N/AMaintains
4 years ago
Freeline Therapeutics Holdings PLCFRLN
2Strong Buy$330.00N/AMaintains
4 years ago
Regenxbio IncRGNX
4Strong Buy$62.00N/AMaintains
4 years ago
Huntington Bancshares IncHBAN
1Hold$17.25N/AMaintains
4 years ago
Unity Biotechnology IncUNBX
4Hold$50.00N/ADowngrades
5 years ago
Immunomedics IncIMMU
1Hold$22.00N/AMaintains
5 years ago
Global Blood Therapeutics IncGBT
6Hold$70.00N/AMaintains
5 years ago
Alexion Pharmaceuticals IncALXN
9Hold$116.00N/AMaintains
5 years ago
Rubius Therapeutics IncRUBY
1Hold$4.00N/ADowngrades
5 years ago
Forty Seven IncFTSV
2Hold$95.50N/ADowngrades
5 years ago
Incyte CorpINCY
1Hold$83.00N/AMaintains
6 years ago
Ultragenyx Pharmaceutical IncRARE
4Strong Buy$83.00N/AUpgrades
6 years ago
Celgene CorpCELG
8Hold$88.00N/AMaintains
7 years ago
Radius Health IncRDUS1
4Strong Buy$57.00N/AMaintains
7 years ago
Portola Pharmaceuticals IncPTLA
6Hold$32.00N/AMaintains
7 years ago
Loxo Oncology IncLOXO
6Strong Buy$213.00N/AMaintains
7 years ago
Cytokinetics IncCYTK
4Hold$10.00N/AAssumes
7 years ago
Bioverativ IncBIVV
2HoldN/AN/AUpgrades
7 years ago
Juno Therapeutics IncJUNO
1Hold$43.00N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.